Indivior Announces Q2 2024 Financial Results

Rhea-AI Summary

Indivior PLC (Nasdaq/LSE: INDV) has announced its financial results for the quarter ending June 30, 2024. The company has made available its earnings release, investor presentation, and webcast on its official website at www.indivior.com. A live webcast presentation is scheduled for 13:00 BST (8:00 am ET), to be hosted by CEO Mark Crossley. Interested parties can access the presentation through a webcast link or by registering for telephonic participation. The event provides an opportunity for investors and analysts to gain insights into Indivior's Q2 2024 financial performance and potentially discuss future outlook and strategies.

SLOUGH, UK and RICHMOND, Va., July 25, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending June 30, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com.

• The earnings release can be found at www.indivior.com/investors
• The investor presentation can be found at www.indivior.com/investors (at 7:00 am ET)

There will be a live webcast presentation at 13:00 BST (8:00 am ET) hosted by Mark Crossley, CEO. The details are below.

Webcast link: https://edge.media-server.com/mmc/p/jpgy4cd9
Participants may access the presentation telephonically by registering with the following link: https://register.vevent.com/register/BIdf08b662a5f24248bf5f8677f59ef713

(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration) 

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD), overdose and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in the United States in Richmond, VA, Indivior employs approximately 1,100 individuals globally and its portfolio of products is available in 37 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-announces-q2-2024-financial-results-302205638.html

SOURCE Indivior PLC

FAQ

When did Indivior PLC (INDV) release its Q2 2024 financial results?

Indivior PLC (INDV) released its Q2 2024 financial results on July 25, 2024.

Where can investors find Indivior's (INDV) Q2 2024 earnings release and presentation?

Investors can find Indivior's (INDV) Q2 2024 earnings release and presentation at www.indivior.com/investors.

When is Indivior's (INDV) Q2 2024 earnings webcast scheduled?

Indivior's (INDV) Q2 2024 earnings webcast is scheduled for 13:00 BST (8:00 am ET) on July 25, 2024.

Who will host Indivior's (INDV) Q2 2024 earnings webcast?

Indivior's (INDV) Q2 2024 earnings webcast will be hosted by CEO Mark Crossley.